Sue Killion Cammarata MD

Pulmonology•Chicago, IL

Critical Care Medicine, Sleep Medicine

Senior Clinical Subject Matter Expert to Biomedical Advanced Research and Development Authority (BARDA)

Join to View Full Profile

ChicagoChicago, IL 60654

Education & Training

Henry Ford Health/Henry Ford HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1986 - 1989
Michigan State University College of Human MedicineClass of 1986

Certifications & Licensure

MI State Medical License 1987 - 2027
American Board of Internal Medicine Internal Medicine
American Academy of Sleep MedicineSleep Medicine

Clinical Trials

Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2013 Apr 01
Completed
Phase 3
Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections Start of enrollment: 2014 May 01
Completed
Phase 3
Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea Start of enrollment: 2014 Jan 23
Terminated
Phase 3
Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment Start of enrollment: 2014 Sep 01
Completed
Phase 1
Study to Evaluate the Effect of Delafloxacin on the Pharmacokinetics of Midazolam in Healthy Subjects Start of enrollment: 2015 Jun 01
Completed
Phase 1
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia Start of enrollment: 2016 Dec 14
Completed
Phase 3
Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults Start of enrollment: 2018 Apr 30
Completed
Phase 1
Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers Start of enrollment: 2018 May 01
Completed
Phase 1
Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients Start of enrollment: 2019 Jul 16
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
Hiwot Hiruy, Shukal Bala, James M Byrne, Kerian Grande Roche, Seong H Jang
Clinical Infectious Diseases. 2024-07-24
6 citations
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.
S M Bhavnani, M Trang, D C Griffith, O Lomovskaya, J P Hammel
Antimicrobial Agents and Chemotherapy. 2022-12-20
9 citations
Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from t...
Sandra P. McCurdy, Ashley Nenninger, Amanda Sheets, Kara Keedy, Laura Lawrence
International Journal of Infectious Diseases. 2020-08-01

Press Mentions

Why This FDA Approval for Pneumonia Treatment Is so HugeJune 19th, 2019
Melinta Therapeutics to Present at Making a Difference in Infectious Diseases (MAD-ID) 2019 Annual MeetingMay 7th, 2019
Melinta Therapeutics Announces Multiple Presentations at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)April 8th, 2019
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member
American College of Chest Physicians - ACCP
Fellow
American Thoracic Society - ATS
Member
Infectious Disease Society of America - IDSA
Member
American Academy of Sleep Medicine - AASM
Fellow
American Academy of Sleep Medicine - AASM
Member

External Links

BARDAhttp://Www.medicalcountermeasures.gov